SAN DIEGO, Sept. 11, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”), today announced that the company will be featured as a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference being held September 10-12, 2017 at the Lotte New York Palace Hotel in New York, NY.
TearLab’s management will provide a corporate overview and business update on the company during the presentation at the conference.
Details of the presentations are as follows:
|Date:||Tuesday, September 12, 2017|
|Time:||2:35- 3:00 PM ET|
|Location:||Holmes II Room|
The presentation will be webcast and available for replay in the Investor Section of TearLab’s website www.tearlab.com.
About TearLab Corporation
TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.
The Ruth Group